Your browser doesn't support javascript.
Contemplating HPV vaccination in Japan during the time of COVID-19.
Miyoshi, Ai; Ueda, Yutaka; Kimura, Tadashi.
  • Miyoshi A; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Ueda Y; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Kimura T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan.
Hum Vaccin Immunother ; 17(3): 836-837, 2021 03 04.
Article in English | MEDLINE | ID: covidwho-786983
Semantic information from SemMedBD (by NLM)
1. Cervical Cancer Screening TREATS Females
Subject
Cervical Cancer Screening
Predicate
TREATS
Object
Females
2. Adverse event CAUSES Labor (Childbirth)
Subject
Adverse event
Predicate
CAUSES
Object
Labor (Childbirth)
3. Adverse event PROCESS_OF Woman
Subject
Adverse event
Predicate
PROCESS_OF
Object
Woman
4. Vaccinated at PROCESS_OF Woman
Subject
Vaccinated at
Predicate
PROCESS_OF
Object
Woman
5. Human Papilloma Virus Vaccine PREVENTS Malignant tumor of cervix
Subject
Human Papilloma Virus Vaccine
Predicate
PREVENTS
Object
Malignant tumor of cervix
6. Cervical Cancer Screening TREATS Females
Subject
Cervical Cancer Screening
Predicate
TREATS
Object
Females
7. Adverse event CAUSES Labor (Childbirth)
Subject
Adverse event
Predicate
CAUSES
Object
Labor (Childbirth)
8. Adverse event PROCESS_OF Woman
Subject
Adverse event
Predicate
PROCESS_OF
Object
Woman
9. Vaccinated at PROCESS_OF Woman
Subject
Vaccinated at
Predicate
PROCESS_OF
Object
Woman
10. Human Papilloma Virus Vaccine PREVENTS Malignant tumor of cervix
Subject
Human Papilloma Virus Vaccine
Predicate
PREVENTS
Object
Malignant tumor of cervix
ABSTRACT
The Coronavirus Disease 2019 (COVID-19) pandemic has been growing, including in Japan where it has been estimated that as many as 3.1% of patients positive for new CoV strain SARS-CoV-2 might die of COVID-19-related respiratory failure. Meanwhile, human papillomavirus (HPV) is spreading in Japan. The fatality rate for HPV-associated cancers after infection with HPV is as much as that for COVID-19 in Japan, although the time to disease is much longer for HPV. Among advanced countries, the cervical cancer screening rate in Japanese females is very low. The Japanese Ministry of Health, Labor and Welfare (MHLW) suspended its official recommendation for HPV vaccination in June 2013 due to alleged adverse post-vaccination events in several young girls, such as chronic pain and motor impairment, which were repeatedly reported in the media. Subsequently, the rate for vaccinating girls plummeted from approximately 70% to the current rate of 1% or less. Women should accept HPV vaccination for the eventual prevention of cervical cancer with the same passion they are for COVID-19 testing.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Papillomavirus Infections / Alphapapillomavirus / Papillomavirus Vaccines / COVID-19 Type of study: Diagnostic study / Screening study Topics: Vaccines Limits: Female / Humans Country/Region as subject: Asia Language: English Journal: Hum Vaccin Immunother Year: 2021 Document Type: Article Affiliation country: 21645515.2020.1801318

Full text: Available Collection: International databases Database: MEDLINE Main subject: Papillomavirus Infections / Alphapapillomavirus / Papillomavirus Vaccines / COVID-19 Type of study: Diagnostic study / Screening study Topics: Vaccines Limits: Female / Humans Country/Region as subject: Asia Language: English Journal: Hum Vaccin Immunother Year: 2021 Document Type: Article Affiliation country: 21645515.2020.1801318